期刊文献+

前列腺癌患者手术去势对代谢综合征发病的影响

Impact of surgical castration on the pathogenesis of metabolic syndrome in males of prostate cancer
原文传递
导出
摘要 目的比较前列腺癌患者手术去势及根治术后代谢综合征(MS)发病情况,分析睾酮水平对MS的影响。方法选取50例早期前列腺癌患者行根治性切除术、50例晚期前列腺癌患者行手术去势,另选行健康体检的50例老年男性,随访至少18个月,监测其血液中睾酮浓度及MS各相关指标,比较MS发病情况并分析睾酮水平对MS的影响。结果手术去势组的体质量、体质量指数(BMI)、腰围、甘油三酯(TG)、空腹血糖(FPG)及血压(收缩压DBP,舒张压SBP)明显高于根治组和正常组(P〈0.01),而血清总睾酮(TT)、高密度脂蛋白(HDL)明显低于根治组和正常组(P〈0.01),三组间总胆固醇(TC)、低密度脂蛋白差异无统计学意义(P〉0.05)。结论前列腺癌患者手术去势后MS发病率明显增加,提示MS的发生与低睾酮水平明显相关。 Objective Compare the incidence of metabolic syndrome after surgical castration and radical surgery in males with prostate cancer, and analyze the effect of testosterone on metabolic syndrome. Methods Fifty patients with early prostate cancer patients who underwent radical resection and 50 patients with advanced prostate cancer who received surgical castration and 50 healthy elderly men were enrolled in the study. They were followed-up at least 18 months, and their testosterone level and the indicators of metabolic syndrome were monitored. Results Weight,body mass index(BMI), waist circumference(WC), triglycerides(TG), fasting blood glucose(FBG) and blood pressure in surgical castration group were significantly higher than those in radical resection group and normal control group(P〈0.01),whereas their total serum testosterone level and high density lipoprotein(LDL) level were significantly lower than that of radical resection group and normal control group(P〈0.01). There were no significant differences in cholesterol and low density lipoprotein(LDL) among those groups(P〉0.05). Conclusion Incidence of metabolic syndrome increased significantly after surgical castration,suggesting that the occurrence of metabolic syndrome was associated with low testosterone level.
出处 《中国男科学杂志》 CAS CSCD 北大核心 2013年第8期33-35,38,共4页 Chinese Journal of Andrology
基金 基金项目资助:本课题受安徽高校省级自然科学研究项目(KJ2011A169)基金资助
关键词 前列腺肿瘤 睾丸切除术 代谢综合征 prostatic neoplasms, Orchiectomy metabolic syndrome
  • 相关文献

参考文献11

  • 1Day C. Metabolic syndrome,or what you will:definitions and epidemiology.Diab Vasc Dis Res 2007; 4(1): 32-38.
  • 2Muller M, Grobbee DE, den Tonkelaar I, eta1. Endogenous sex hormones and metabolic syndrome in aging men. J Clin EndocnnolMetab 2005; 90(5): 2618-2623.
  • 3Svartberg J, von Muhlen D, Sundsfjord J, et M. Waist circumference and testosterone levels in community dwelling men. EurJEpidemio12004; 19(7): 657-663.
  • 4Haidar A, Yassin A, Saad F, et al. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes.AgingMale 2007; 10(4): 189-196.
  • 5Haddad RM, Kennedy CC, Caples SM, et aL Testosterone and cardiovascular risk in men:a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82(1): 29-39.
  • 6关迪,谷翊群.男性雄激素缺乏症与代谢综合征[J].国际生殖健康/计划生育杂志,2011,30(1):21-25. 被引量:8
  • 7Yeap BB, Hyde Z, Almeida OP, eta/. Lower testosterone levels predict incident stroke and transient ischemic attackin older men. J Clin Endocrinol Metab 2009; 94(7): 2353-2359.
  • 8Yeap BB, Hyde Z, Norman PE, etal. Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men. J Clin EndocrinolMetab 2010; 95(3): 1123-1130.
  • 9Pitteloud N, Mootha VK, Dwyer AA, et al. Relationship between testosterone levels,insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005; 28(7): 1636-1642.
  • 10Corona G, Rastrelli G, Vignozzi L, et al. Testosterone, car diovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 2011; 25(2): 337-353.

二级参考文献37

  • 1Kupelian V, Page ST, Araujo AB,et al. Low sex hormone binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men [J]. J Clin Endocrinol Metab, 2006,91 ( 11 ) : 843-850.
  • 2Chubb SA, Hyde Z, Almeida OP, et al. Lower sex hormone binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men:the Health in Men Study [J]. Eur J Endocrinol,2008, 158(6):785-792.
  • 3Rodriguez A. Muller DC, Metter E J, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging[J]. J Clin Endocrinol Metab, 2007,92( 9 ) : 3568-3572.
  • 4Allan CA, Strauss BJ, McLachlan RI. Body composition, metabolic syndrome and testosterone in ageing men[J].Int J Impot Res, 2007,19( 5 ) : 448-457.
  • 5Kalyani RR, Dobs AS. Androgen deficiency,diabetes,and the metabolic syndrome in men [J]. Curr Opin Endocrinol Diabetes Obes,2007,14( 3 ) : 226-234.
  • 6Saad F, Gooren L J, Haider A, et al. A dose-response study of testosterone on sexual dysfunction and feature's of the metabolic syndrome using tcstosterone gel and parenteral testosterone undecanoate[J]. J Androl,2008,29( 1 ): 102-105.
  • 7Selvin E, Fcinleib M, Zhang L, et al. Androgens and diabetes in men:results from the Third National Health and Nutrition Examination Survey (NHANES lll)[J]. Diabetes Care,2007,30 ( 2 ) : 234-238.
  • 8Svartberg J. Epidemiology: testosterone and the metabolic syndrome[J]. Int J Impot Res, 2007, 19(2 ) : 124-128.
  • 9Jackson G. Sexual dysfunction and diabetes Int [J]. J Clin Pract, 2004,58(4) :358-362.
  • 10Kohn FM. Testosterone and body functions [J]. Aging Male, 2006, 9(4):183-188.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部